Sagenome develops test kit to predict severity of Covid disease

Sagenome develops test kit to predict severity of Covid disease

Kochi-based biotechnology start-up, Sagenome has created a test kit for genomic analysis that might help anticipate the risks of developing serious COVID-related illness if infected. The test kit called ‘COVIGENE’ was developed on the firm’s OhMyGene platform and will give enough information to assist people in preparing for treatments and assuring proper management.

It offers a genetic variant test that can be used to determine the severity of COVID illness.

Source state that COVID-related morbidity and mortality rise sharply with age as well as with co-existing medical problems like cancer and cardiovascular disease. The presence of underlying genetic factors also increase the severity of the illness to a larger extent.

Individuals infected with SARS-CoV-2 undergo an extreme variation of the disease, ranging from lack of symptoms to quickly worsening last-stage pulmonary disease. Still, COVID is bizarrely and tragically selective.

Former Director of Rajiv Gandhi Centre for Biotechnology, M Radhakrishna Pillai and former CMD of HLL Lifecare Limited (HLL), M Ayyappan founded SAGENOME, which is incubated at Kerala Startup Mission in Kochi.

COVIGENE, according to Pillai, gives data on probable illness course prediction based on the profile of four genes.

He said that the understanding of Covid-19 has been inadequate for using clinical risk models. The genetic profile addition to the clinical modeling will be enormously helpful. COVIGENE will also help older people and comorbidities, including cardiovascular disease, diabetes, COPD (chronic obstructive pulmonary disease), and cancer.

Mr. Pillai continued that during the outbreak, their firm’s expertise focused on recognizing and authenticating gene variants associated with Covid-19 severity. They used this research tool to investigate if an individual has higher genetic chances of developing a serious disease.

It can be used further to discuss the options with healthcare professionals when diagnosed with a Covid infection.

Source Credit -